Riskpilot← Back to searchSign inGet full accessCROXX MED ApS
APSActiveCVR 33247117Agern Alle 24All other professional, scientific and technical activities n.e.c. · NACE 7499Est. 201013 employees
Revenue 2025
DKK 4,7M
-38% vs 2024
EBITDA margin
-2.0%
-103% vs 2024
Equity ratio
55.4%
Financial strength
Net profit 2025
DKK 121K
-95% vs 2024
| Revenue | DKK 4,7M | -38% |
| EBITDA | DKK -95K | -103% |
| Net profit | DKK 121K | -95% |
| Total assets | DKK 4,2M | -13% |
| Equity | DKK 2,3M | -32% |
| Employees | 13 | — |
Legal name
CROXX MED ApS
CVR number
33247117
Legal form
Anpartsselskab
NACE code
7499 · All other professional, scientific and technical activities n.e.c.
Founded
14. oktober 2010
Share capital
DKK 80.000
Employees
13 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2025-06-30
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør.
Company purpose
Selskabets formål er at drive virksomhed som konsulent inden for healthcare og dermed beslægtet virksomhed.
Address
Agern Alle 24
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2.809 | 3.051 | 796 | 504 | 3.180 | 2.180 | 2.164 | 4.432 | 4.862 | 6.907 | 8.006 | 6.365 | 7.545 | 4.711 |
| Staff expenses | -2.258 | -2.308 | -1.532 | -500 | -2.682 | -2.656 | -1.995 | -3.374 | -3.612 | -4.681 | -4.802 | -4.980 | -4.613 | -4.806 |
| EBITDA | 551 | 743 | -736 | 4 | 500 | -476 | 170 | 1.058 | 1.250 | 2.226 | 3.204 | 1.176 | 2.932 | -95 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 | -0 | -5 | -7 | -8 | -0 | -0 | -0 | -0 | -0 |
| EBIT | 551 | 743 | -736 | 4 | 500 | -476 | 165 | 1.051 | 1.242 | 2.226 | 3.204 | 1.176 | 2.932 | -95 |
| Net financials | -6 | -3 | -41 | -86 | -92 | -76 | -65 | -50 | -36 | -55 | -20 | 17 | 40 | 30 |
| Profit before tax | 544 | 740 | -777 | -81 | 406 | -552 | 100 | 1.001 | 1.205 | 2.170 | 3.184 | 1.193 | 2.972 | -65 |
| Tax | 140 | 219 | -192 | 22 | -1 | -0 | -103 | 102 | 272 | 486 | 707 | 265 | 657 | -187 |
| Net profit | 404 | 521 | -585 | -104 | 409 | -552 | 203 | 899 | 933 | 1.684 | 2.477 | 928 | 2.315 | 121 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 1.363 | 1.548 | 1.706 | 1.374 | 2.601 | 1.443 | 1.526 | 2.915 | 3.482 | 3.645 | 4.944 | 3.782 | 4.853 | 4.225 |
| Equity | 489 | 710 | -175 | -279 | 130 | -421 | -219 | 681 | 1.614 | 1.399 | 2.875 | 2.303 | 3.418 | 2.340 |
| Long-term debt | 120 | 74 | 764 | 850 | 833 | 531 | 360 | 321 | 285 | 502 | 711 | 262 | 489 | 0 |
| Short-term debt | 733 | 596 | 1.117 | 803 | 1.638 | 1.333 | 1.385 | 1.911 | 1.582 | 1.738 | 1.355 | 1.211 | 773 | 1.885 |
| Total debt | 853 | 670 | 1.881 | 1.653 | 2.471 | 1.864 | 1.744 | 2.233 | 1.867 | 2.240 | 2.066 | 1.474 | 1.261 | 1.885 |
EBITDA margin
-2.0%
This company
15.8%
Market median
-113% vs market
20122025
Equity ratio
55.4%
This company
38.2%
Market median
+45% vs market
20122025
Return on equity
5.2%
This company
18.4%
Market median
-72% vs market
20122025
Net profit margin
2.6%
This company
8.1%
Market median
-68% vs market
20122025
Asset turnover
1.12×
This company
1.12×
Market median
+0% vs market
20122025
Debt / equity
0.81×
This company
0.62×
Market median
+31% vs market
20122025
- Annual report 2025Filed via CVR / Virk · Period 2024-07-01 – 2025-06-30
- Annual report 2024Filed via CVR / Virk · Period 2023-07-01 – 2024-06-30
- Annual report 2023Filed via CVR / Virk · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via CVR / Virk · Period 2021-07-01 – 2022-06-30
- Annual report 2021Filed via CVR / Virk · Period 2020-07-01 – 2021-06-30
- Annual report 2020Filed via CVR / Virk · Period 2019-07-01 – 2020-06-30
- Annual report 2019Filed via CVR / Virk · Period 2018-07-01 – 2019-06-30
- Annual report 2018Filed via CVR / Virk · Period 2017-07-01 – 2018-06-30
- Annual report 2017Filed via CVR / Virk · Period 2016-07-01 – 2017-06-30
- Annual report 2016Filed via CVR / Virk · Period 2015-07-01 – 2016-06-30
- Annual report 2015Filed via CVR / Virk · Period 2014-07-01 – 2015-06-30
- Annual report 2014Filed via CVR / Virk · Period 2013-07-01 – 2014-06-30
- Annual report 2013Filed via CVR / Virk · Period 2012-07-01 – 2013-06-30
- Annual report 2012Filed via CVR / Virk · Period 2011-07-01 – 2012-06-30
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
BT Management | Management | 2010 | — | — |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
CROXXMED HOLDING ApS | Company | 66.7% | 66.7% | 2012 |
I-S-A HOLDING ApS | Company | 15.0% | 15.0% | 2012 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
I-S-A HOLDING ApS
CROXX MED ApS Board members of CROXX MED ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Birgitte Telmer | Management | 0 companies |